title: Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications.
abstract: BACKGROUND
  Many biomedical applications require the expression or production of therapeutic hetero-multimeric proteins/protein complexes: in most cases only accomplished by co-ordinated co-expression within the same cell. Foot-and-mouth disease virus 2A (F2A) and '2A-like' sequences are now widely used for this purpose. Since 2A mediates a co-translational 'cleavage' at its own C-terminus, sequences encoding multiple proteins (linked via 2As) can be concatenated into a single ORF: a single transgene. It has been shown that in some cases, however, the cleavage efficiency of shorter versions of F2A may be inhibited by the C-terminus of certain gene sequences immediately upstream of F2A. This paper describes further work to optimise F2A for co-expression strategies.
  
  
  RESULTS
  We have inserted F2A of various lengths in between GFP and CherryFP 'reporter' proteins (in reciprocal or tandem arrangements). The co-expression of these proteins and cleavage efficiencies of F2As of various lengths were studied by in vitro coupled transcription and translation in rabbit reticulocyte lysates, western blotting of HeLa cell lysates and fluorescence microscopy.
  
  
  CONCLUSIONS
  Optimal and suboptimal lengths of F2A sequences were identified as a result of detailed 'fine-tuning' of the F2A sequence. Based on our data and the model according to which 2A activity is a product of its interaction with the exit tunnel of the ribosome, we suggest the length of the F2A sequence which is not 'sensitive' to the C-terminus of the upstream protein that can be successfully used for co-expression of two proteins for biomedical applications.
authors: Biomedical Sciences Research Complex, North Haugh, University of St,Andrews, St,Andrews, KY16 9ST Fife, Scotland, UK. minskayakat@hotmail.com
authors: Ekaterina
authors: E
authors: Minskaia
authors: John
authors: J
authors: Nicholson
authors: Martin D
authors: MD
authors: Ryan
mesh_terms: D000595:Amino Acid Sequence; D029544:Foot-and-Mouth Disease Virus / Q000235:genetics* / Q000378:metabolism*; D015870:Gene Expression; D017930:Genes, Reporter; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D008856:Microscopy, Fluorescence; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics; D019076:Transgenes; D014764:Viral Proteins / Q000235:genetics*
chemical_list: D014764:Viral Proteins; C057421:virus protein 2A; D049452:Green Fluorescent Proteins
references: Nat Biotechnol. 2004 May;22(5):589-94
references: 15064769
references: J Gen Virol. 2008 Apr;89(Pt 4):1036-1042
references: 18343847
references: Gene Ther. 2001 Jun;8(11):864-73
references: 11423934
references: Gene Ther. 1999 Feb;6(2):198-208
references: 10435104
references: Biologicals. 2010 Sep;38(5):586-93
references: 20682459
references: Biomed Res Int. 2013;2013:291730
references: 23878801
references: Cell Struct Funct. 2011;36(2):209-22
references: 21979235
references: Drug News Perspect. 2008 Nov;21(9):473-80
references: 19180265
references: Curr Opin Biotechnol. 1999 Oct;10(5):458-64
references: 10508627
references: Anal Biochem. 2005 Aug 1;343(1):116-24
references: 15955524
references: J Gen Virol. 2001 May;82(Pt 5):1027-1041
references: 11297677
references: BMC Biol. 2008 Sep 15;6:40
references: 18793381
references: Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):157-62
references: 19109433
references: Traffic. 2004 Aug;5(8):616-26
references: 15260831
references: Stem Cells. 2008 Oct;26(10):2455-66
references: 18617691
references: RNA. 2007 Jun;13(6):803-10
references: 17456564
references: J Biol Chem. 2003 Mar 28;278(13):11441-8
references: 12522142
references: Gene Ther. 2002 Mar;9(5):337-44
references: 11938453
references: J Gen Virol. 1991 Nov;72 ( Pt 11):2727-32
references: 1658199
references: EMBO J. 1994 Feb 15;13(4):928-33
references: 8112307
references: Gene Ther. 2008 Nov;15(21):1411-23
references: 18496571
references: Nat Biotechnol. 2005 May;23(5):584-90
references: 15834403
references: Cell Res. 2009 Mar;19(3):296-306
references: 19238173
references: J Gen Virol. 2008 Feb;89(Pt 2):389-396
references: 18198369
references: Gene Ther. 2001 May;8(10):811-7
references: 11420646
references: J Immunol Methods. 2011 Sep 30;372(1-2):30-41
references: 21782818
references: Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4733-8
references: 18326627
references: Nucleic Acids Res. 2005 Nov 28;33(20):6593-602
references: 16314320
references: J Cell Physiol. 2009 Feb;218(2):323-33
references: 18932205
references: Stem Cells. 2009 Mar;27(3):543-9
references: 19096035
references: Genesis. 2007 Oct;45(10):625-9
references: 17941043
references: Curr Gene Ther. 2002 Sep;2(3):355-78
references: 12189721
references: Biotechnol J. 2010 Feb;5(2):213-23
references: 19946875
references: Nucleic Acids Res. 2012 Apr;40(7):3143-51
references: 22140113
references: Gene Ther. 2008 Apr;15(8):625-31
references: 18305579